Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Olmesartan/Amlodipine/HCTZ vs Tribenzor in Healthy Subjects
NCT02962336Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of olmesartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started May 2011; status: completed.
02
Drugs
olmesartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02962336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962336.